Guideline for the investigation and management of eosinophilia

被引：124
作者：
Butt, Nauman M. [1 ]
Lambert, Jonathan [2 ]
Ali, Sahra [3 ]
Beer, Philip A. [4 ]
Cross, Nicholas C. P. [5 ]
Duncombe, Andrew [6 ]
Ewing, Joanne [7 ]
Harrison, Claire N. [8 ]
Knapper, Steven [9 ]
McLornan, Donal [10 ]
Mead, Adam J. [11 ,12 ]
Radia, Deepti [8 ]
Bain, Barbara J. [13 ]
机构：
[1] Royal Liverpool & Broadgreen Univ Teaching Hosp N, Liverpool, Merseyside, England
[2] Univ Coll London Hosp NHS Fdn Trust, London, England
[3] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[4] Wellcome Trust Sanger Inst, Cambridge, England
[5] Univ Southampton, Fac Med, Southampton, Hants, England
[6] Southampton Univ Hosp, Dept Haematol, Southampton, Hants, England
[7] Heart England NHS Fdn Trust, Birmingham, W Midlands, England
[8] Guys & St Thomas NHS Fdn Trust, London, England
[9] Cardiff Univ, Div Canc & Genet, Sch Med, Cardiff, S Glam, Wales
[10] Kings Coll Hosp NHS Fdn Trust, London, England
[11] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England
[12] NIHR Oxford Biomed Ctr, BRC Blood Theme, Oxford, England
[13] Imperial Coll London, St Marys Hosp, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 176卷 / 04期
基金：
英国医学研究理事会;
关键词：
eosinophilia; hypereosinophilia; eosinophilic leukaemia; hypereosinophilic syndrome; IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; TERM-FOLLOW-UP; ATHEROEMBOLIC RENAL-DISEASE; VERSUS-HOST-DISEASE; ALPHA-INTERFERON; EPISODIC ANGIOEDEMA; CLINICOPATHOLOGIC CORRELATION; MYELOPROLIFERATIVE DISORDERS; ANTI-INTERLEUKIN-5; ANTIBODY; CLINICAL-MANIFESTATIONS;
D O I：
10.1111/bjh.14488
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：553 / 572
页数：20
相关论文
共 120 条
  • [1] Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders
    Ackerman, Steven J.
    Bochner, Bruce S.
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2007, 27 (03) : 357 - +
  • [2] Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
    Agarwal, R.
    Chakrabarti, A.
    Shah, A.
    Gupta, D.
    Meis, J. F.
    Guleria, R.
    Moss, R.
    Denning, D. W.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (08) : 850 - 873
  • [3] Hypersensitivity myocarditis presenting as cardiogenic shock
    Aggarwal, A
    Bergin, P
    Jessup, P
    Kaye, D
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (11) : 1241 - 1244
  • [4] Incidence and Prognostic Value of Eosinophilia in Chronic Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation
    Ahmad, Imran
    Labbe, Annie-Claude
    Chagnon, Miguel
    Busque, Lambert
    Cohen, Sandra
    Kiss, Thomas
    Lachance, Silvy
    Roy, Denis-Claude
    Sauvageau, Guy
    Roy, Jean
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (11) : 1673 - 1678
  • [5] Akiyama Y, 1997, Nihon Kyobu Shikkan Gakkai Zasshi, V35, P541
  • [6] Association of the blood eosinophil count with hematological malignancies and mortality
    Andersen, Christen L.
    Siersma, Volkert D.
    Hasselbalch, Hans C.
    Vestergaard, Hanne
    Mesa, Ruben
    Felding, Peter
    Olivarius, Niels D. F.
    Bjerrum, Ole W.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (03) : 225 - 229
  • [7] The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRα-positive hypereosinophilic syndrome. Results of a multicenter prospective study
    Baccarani, Michele
    Cilloni, Daniela
    Rondoni, Michela
    Ottaviani, Emanuela
    Messa, Francesca
    Merante, Serena
    Tiribelli, Mario
    Buccisano, Francesco
    Testoni, Nicoletta
    Gottardi, Enrico
    de Vivo, Antonio
    Giugliano, Emilia
    Iacobucci, Ilaria
    Paolini, Stefania
    Soverini, Simona
    Rosti, Gianantonio
    Rancati, Francesca
    Astolfi, Cinzia
    Pane, Fabrizio
    Saglio, Giuseppe
    Martinelli, Giovanni
    [J]. HAEMATOLOGICA, 2007, 92 (09) : 1173 - 1179
  • [8] Bain B J., 2008, World Health Organization classification of tumours of haematopoietic and lymphoid tissues, V4th, P51
  • [9] Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?
    Bain, Barbara J.
    Ahmad, Shahzaib
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (06) : 809 - 817
  • [10] Barouky R, 2003, EUR J DERMATOL, V13, P207
12345678910